Camex Ltd

Meeting Details

• Date: October 23, 2026; Venue: Registered Office.

Key Agenda Items

• Consider and approve Un-Audited Financial Results for Q2 and H1 FY2026 (Sept 30, 2026) per IND-AS, Limited Review.

Camex Ltd – Closure of Trading Window from October 1, 2026 until 48 hours after the announcement of Un-Audited Financial Results for the half year ended on September 30, 2026

09-09-2026 – 1 share

• Target: Camex Limited; Disclosing Party: Nahata Khushii Rajesh; non-promoter.
• Transaction: Acquisition of equity shares through open market.
• Pre-transaction holding: 31,222 shares; post-transaction holding: 31,223 shares.
• Acquired: 1 share; instrument: equity shares.
• Share capital before/after: Rs 10,20,87,000; diluted capital unchanged.

24-08-2026 – 6,104 shares

• Target: Camex Limited; Disclosing Party: Nahata Khushii Rajesh; non-promoter.
• Transaction: Acquisition of equity shares through open market.
• Pre-transaction holding: 31,118 shares; post-transaction holding: 37,222 shares.
• Acquired: 6,104 shares; instrument: equity shares.
• Share capital before/after: Rs 10,20,87,000; diluted capital unchanged.

22-09-2026 – 100 shares

• Target: Camex Limited; Disclosing Party: Nahata Khushii Rajesh; non-promoter.
• Transaction: Acquisition of equity shares through open market.
• Pre-transaction holding: 31,118 shares; post-transaction holding: 31,218 shares.
• Acquired: 100 shares; share percentage: 0.001%.
• Share capital before/after: Rs 10,20,87,000; diluted capital unchanged.

Price movement clarification

• No undisclosed price-sensitive information or impending corporate action at this time.
• Price movement is market-driven and not connected to management.
• Company will continue to disclose timely as required under SEBI LODR and on its website.

Financials

• Revenue from operations ₹4,082.59 lakhs; total revenue ₹4,091.29 lakhs in Q1FY26.
• Profit before tax ₹188.92 lakhs; tax ₹50.12 lakhs; PAT ₹139.59 lakhs.
• EPS Basic ₹1.37; Diluted ₹1.37.
• Total expenses ₹3,902.37 lakhs; cost of materials ₹1,759.31; stock-in-trade ₹1,666.01.
• Other income ₹8.70 lakhs; finance costs ₹48.41 lakhs; depreciation ₹19.00 lakhs.
• Segment revenue: Dyes and Chemicals ₹2,426.88 lakhs; Fiber Glass ₹1,655.71 lakhs.
• Segment results before finance: Dyes ₹108.18 lakhs; Fiber Glass ₹129.15 lakhs.

Segment & balance sheet

• Segment assets: Dyes and Chemicals ₹4,084.32 lakhs; Fiber Glass ₹3,289.55 lakhs; total ₹7,373.87 lakhs.
• Segment liabilities: Dyes ₹1,037.46 lakhs; Fiber Glass ₹1,561.17 lakhs; total ₹2,598.63 lakhs.

Board action

• Board approved unaudited results for quarter ended 30 Jun 2026; Limited Review Report attached.

AGM Details

• Date/time/mode: 7 Aug 2026, 12:30–13:10 IST, via VC/OAVM.
• Record date: 31 Jul 2026; postal ballot last date: 7 Aug 2026.
• Total shareholders on record: 4,022.
• Attendance: Promoters 6, Public 17 via VC.
• All resolutions were passed.

Key Resolutions

• Resolution 1 (Ordinary): Adoption of Audited Financial Statements for year ended 31 March 2026.
• Resolution 2 (Ordinary): Reappointment of Rajesh Nahata by rotation.
• Resolution 3 (Ordinary): Approval of related party transactions with Camex Industries and Camex Wellness Limited.
• Resolution 4 (Ordinary): Approval of related party transactions with Texchem Private Limited.
• Resolution 5 (Ordinary): Approval of related party transactions with Camex Wellness Limited for goods.
• Resolution 6 (Ordinary): Approval of related party transactions with Speciality Private Limited.
• Resolution 7 (Ordinary): Approval of related party transactions for rent of premises.
• Resolution 8 (Special): Rental payments to related party for premises.
• Resolution 9 (Ordinary): Approval of related party transactions for unsecured loans with Camex Wellness Limited.
• Resolution 10 (Special): Granting of unsecured loan to Camex Wellness Limited.
• Resolution 11 (Special): Additional unsecured loan arrangements with Camex Wellness Limited.
• Resolution 12 (Ordinary): Acceptance of unsecured loan from Camex Wellness Limited.
• Resolution 13 (Ordinary): Appointment of Khushi Nahata as Whole-Time Director.

Voting Results

• Resolutions 1–7 passed with overwhelming support.
• Resolutions 8, 10, 11 (Special) passed with broad support.
• Resolution 13 passed; overall, no material dissent disclosed.

Related Party Transactions

• Camex Industries and Camex Wellness Limited: sale/purchase of goods and materials.
• Texchem Private Limited: sale/purchase of goods and materials.
• Speciality Private Limited: sale/purchase of goods and materials.
• Rent-related payments to related parties for premises.
• Unsecured loan transactions with Camex Wellness Limited (acceptance/granting).

Directors & Auditors

• Rajesh Nahata reappointed by rotation.
• Khushi Nahata appointed as Whole-Time Director.
• No auditor appointments or changes disclosed.

AGM details

• AGM held Aug 7, 2026 at 12:30 p.m. IST via VC/OAVM.
• Meeting concluded at 1:10 p.m.
• Attendance: 23 members via VC.
• Notice and reports taken as read; no qualifications reported.
• Scrutinizer appointed for remote and on-site voting.
• Remote e-voting: Aug 4–6, 2026; cutoff July 31, 2026.
• Results to be announced within two working days.
• Chaired by Chandraprakash Chopra, MD & Chairman.
• Scrutinizer’s report to be received before declaring results.

Voting and participation

• Remote e-voting conducted Aug 4–6, with cut-off on Jul 31.
• Total attendance: 23 members via VC; no in-person meeting.

Resolutions and outcomes

• Specific resolutions and voting outcomes not detailed in this excerpt.
• Results to be declared within two working days and posted on website.

Auditors and governance

• Statutory, internal, and secretarial auditors attended; no changes announced.

Meeting Details

• Date: August 10, 2026; time not disclosed; venue: Registered Office.

Key Agenda Items

• Consider unaudited quarter ended June 30, 2026 IND-AS results with Limited Review by Statutory Auditors.
• Any other business with the approval of the Board.

Other Notes

• Trading window closed from July 1, 2026, to 48 hours after results adoption.